2024 Partners
Bionaut
Lead Partner
Revolutionizing drug delivery to the brain. Bionaut is a global biotechnology and drug delivery company dedicated to pioneering innovative solutions for brain-targeted therapies. Our cutting-edge precision drug delivery platform enables the accurate, safe, and effective administration of treatments to challenging brain regions for a diverse range of therapeutics. Backed by robust pre-clinical safety data and poised for upcoming 2024 clinical trials, Bionaut is seeking partnerships with forward-thinking pharmaceutical industry pioneers to join our mission. Together, we can unravel the complexities of localized brain conditions and transform neurological care. Join us at the conference and learn more about our mission.
Aptar Pharma
Programme Partner
Aptar Pharma is an expert in nasal drug delivery, offering advanced intranasal systems and drug delivery services from design and manufacture, formulation development and clinical product manufacturing to post launch support. Our global network of GMP manufacturing sites help us accelerate and derisk drug product development, and our investments in R&D and innovation allow us to offer proven nasal drug delivery solutions to help improve patient outcomes across the globe. Aptar Pharma is part of AptarGroup, Inc.
Renishaw
Hosting Partner
Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable therapy infusions in R&D and clinical trials can become a reality.
Our Lab2Clinic™ service supports pharma through the R&D journey, translating into clinical trials and scaled-up commercialisation. We have a wide geographical reach, and we focus on promoting long-term partnerships.
All this is underpinned by our FDA-cleared, CE-marked stereotactic products borne out of a +45-year precision engineering heritage.